Inventor · disambiguated record
Johannes Köbberling
Also filed as: KOBBERLING JOHANNES · Köbberling Johannes
8 granted patents·3 pending applications·20 citations·filing 2012–2020
81Inventor score
Top patents by PatentIndex Score
11 records- 0186US9598417B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2014·Granted Mar 21, 2017·11 cites·10 claims
- 0285US10668071B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2018·Granted Jun 2, 2020·3 cites·17 claims
- 0376US10098883B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2017·Granted Oct 16, 2018·2 cites·12 claims
- 0473US10118930B2Piperidinylpyrazolopyrimidinones and their useBayer Pharma AG·Filed 2015·Granted Nov 6, 2018·3 cites·19 claims
- 0568US9315543B2Tyrosine based linkers for the releasable connection of peptidesBAYER IP GMBH·Filed 2012·Granted Apr 19, 2016·1 cites·6 claims
- 0662US10035818B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBayer Pharma AG·Filed 2017·Granted Jul 31, 2018·0 cites·3 claims
- 0758US9603936B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBAYER IP GMBH·Filed 2012·Granted Mar 28, 2017·0 cites·9 claims
- 0853US9649363B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBAYER IP GMBH·Filed 2015·Granted May 16, 2017·0 cites·9 claims
- 0943US2022387608A1Adrenomedullin-analogues for long-term stabilization and their useBAYER AG·Filed 2020·Application pending·0 cites
- 1039US2018346518A1Lysobactin for use in the treatment of bovine mastitisBAYER ANIMAL HEALTH GMBH·Filed 2016·Application pending·0 cites
- 1132US2018022780A1Stabilization adrenomedullin derivatives and use thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Köbberling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →